Chapter VI
Diseases of the nervous system
(G00-G99)
Diseases of myoneural junction and muscle
(G70-G73)
G70 | Myasthenia gravis and other myoneural disorders Latin: Myasthenia gravis et morbi myoneurales alii | |||||||
Excludes: | botulism (A05.1) transient neonatal myasthenia gravis (P94.0) | |||||||
G70.0 | Myasthenia gravis Latin: Myasthenia gravis | |||||||
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced. | ||||||||
G70.1 | Toxic myoneural disorders Latin: Disordines myoneurales toxici | |||||||
Use additional external cause code (Chapter XX), if desired, to identify toxic agent. | ||||||||
G70.2 | Congenital and developmental myasthenia Latin: Myasthenia congenita evolutionalis | |||||||
G70.8 | Other specified myoneural disorders Latin: Disordines myoneurales specificatae, alii | |||||||
G70.9 | Myoneural disorder, unspecified Latin: Disordo myoneuralis, non specificatus |
G71 | Primary disorders of muscles Latin: Morbi musculorum primarii | |||||||
Excludes: | arthrogryposis multiplex congenita (Q74.3) metabolic disorders (E70-E90) myositis (M60.-) | |||||||
G71.0 | Muscular dystrophy Latin: Dystrophia musculorum | |||||||
Muscular dystrophy: · autosomal recessive, childhood type, resembling Duchenne or Becker · benign [Becker] · benign scapuloperoneal with early contractures [Emery-Dreifuss] · distal · facioscapulohumeral · limb-girdle · ocular · oculopharyngeal · scapuloperoneal · severe [Duchenne] | ||||||||
Excludes: | congenital muscular dystrophy: · NOS (G71.2) · with specific morphological abnormalities of the muscle fibre (G71.2) | |||||||
G71.1 | Myotonic disorders Latin: Disordines myotonici | |||||||
Dystrophia myotonica [Steinert] Myotonia: · chondrodystrophic · drug-induced · symptomatic Myotonia congenita: · NOS · dominant [Thomsen] · recessive [Becker] Neuromyotonia [Isaacs] Paramyotonia congenita Pseudomyotonia | ||||||||
Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced. | ||||||||
G71.2 | Congenital myopathies Latin: Myopathia congenita | |||||||
Congenital muscular dystrophy: · NOS · with specific morphological abnormalities of the muscle fibre Disease: · central core · minicore · multicore Fibre-type disproportion Myopathy: · myotubular (centronuclear) · nemaline | ||||||||
G71.3 | Mitochondrial myopathy, not elsewhere classified Latin: Myopathia mitochoodrialis | |||||||
G71.8 | Other primary disorders of muscles Latin: Morbi musculorum primarii alii | |||||||
G71.9 | Primary disorder of muscle, unspecified Latin: Morbus musculorum primarius, non specificatus | |||||||
Hereditary myopathy NOS |
G72 | Other myopathies Latin: Myopathia aliae | |||||||
Excludes: | arthrogryposis multiplex congenita (Q74.3) dermatopolymyositis (M33.-) ischaemic infarction of muscle (M62.2) myositis (M60.-) polymyositis (M33.2) | |||||||
G72.0 | Drug-induced myopathy Latin: Myopathia medicamentosa | |||||||
Use additional external cause code (Chapter XX), if desired, to identify drug. | ||||||||
G72.1 | Alcoholic myopathy Latin: Myopathia alcoholica | |||||||
G72.2 | Myopathy due to other toxic agents Latin: Myopathia propter factores toxicos alia | |||||||
Use additional external cause code (Chapter XX), if desired, to identify toxic agent. | ||||||||
G72.3 | Periodic paralysis Latin: Paralysis periodica | |||||||
Periodic paralysis (familial): · hyperkalaemic · hypokalaemic · myotonic · normokalaemic | ||||||||
G72.4 | Inflammatory myopathy, not elsewhere classified Latin: Myopathia inflammatoria | |||||||
G72.8 | Other specified myopathies Latin: Myopathiae specificatae, aliae | |||||||
G72.9 | Myopathy, unspecified Latin: Myopathia, non specificata |
G73* | Disorders of myoneural junction and muscle in diseases classified elsewhere Latin: Morbi myoneurales et morbi musculorum in morbis | |||||||
G73.0* | Myasthenic syndromes in endocrine diseases Latin: Syndromae myasthenicae in morbis endocrinis | |||||||
Myasthenic syndromes in: · diabetic amyotrophy (E10-E14+ with common fourth character .4) · thyrotoxicosis [hyperthyroidism] (E05.-+) | ||||||||
G73.1* | Eaton-Lambert syndrome Latin: Syndroma Eaton-Lambert (C80.+)(C80+) | |||||||
G73.2* | Other myasthenic syndromes in neoplastic disease (C00-D48+) Latin: Syndromae myasthenicae ad neoplasma (C00-D48+) | |||||||
G73.3* | Myasthenic syndromes in other diseases classified elsewhere Latin: Syndromae myasthenicae in morbis aliis | |||||||
G73.4* | Myopathy in infectious and parasitic diseases classified elsewhere Latin: Myopathia in morbis infectivis et morbis parasitaris | |||||||
G73.5* | Myopathy in endocrine diseases Latin: Myopathia in morbis endocrinis | |||||||
Myopathy in: · hyperparathyroidism (E21.0-E21.3+) · hypoparathyroidism (E20.-+) Thyrotoxic myopathy (E05.-+) | ||||||||
G73.6* | Myopathy in metabolic diseases Latin: Myopathia in morbis metabolicis | |||||||
Myopathy in: · glycogen storage disease (E74.0+) · lipid storage disorders (E75.-+) | ||||||||
G73.7* | Myopathy in other diseases classified elsewhere Latin: Myopathia in morbis aliis | |||||||
Myopathy in: · rheumatoid arthritis (M05-M06+) · scleroderma (M34.8+) · sicca syndrome [Sjögren] (M35.0+) · systemic lupus erythematosus (M32.1+) |
loading...